Does interleukin-12 play a role in the viral immune response?

Annals of the New York Academy of Sciences

Volumn 795, Issue , 1996, Pages 366-367

  Monteiro, Juanita ^a   Trinchieri, Giorgio ^a  

^a WISTAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; MESSENGER RNA;

CELL PROLIFERATION; CONFERENCE PAPER; CYTOMEGALOVIRUS; CYTOTOXICITY; HELPER CELL; IMMUNE RESPONSE; INFLUENZA; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; NATURAL KILLER CELL; RABIES; T LYMPHOCYTE; VIRUS INFECTION;

EID: 0030460358     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb52694.x     Document Type: Conference Paper

References (17)

1. CHAN, S. H., et al. 1991. Induction of IFN-γ production by NK cell stimulatory factor (NKSF): Characterization of the responder cells and synergy with other inducers. J. Exp. Med. 173: 869-879.
2. D'ANDREA, A., et al. 1992. Production of natural killer cell stimulatory factor (NKSF/ IL-12) by peripheral blood mononuclear cells. J. Exp. Med. 176: 1387-1398.
3. FINKELMAN, F. D., et al. 1994. Effects of interleukin 12 on immune responses and host protection in mice infected with intestinal nematode parasites. J. Exp. Med. 179: 1563-1572.
4. FLESCH, I. E. A., et al. 1995. Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon-γ and tumor necrosis factor alpha. J. Exp. Med. 181: 1615-1621.
5. MANETTI, R., et al. 1993. Natural killer cell stimulatory factor (NKSF/IL-12) induces Th1-type specific immune responses and inhibits the development of IL-4 producing Th cells. J. Exp. Med. 177: 1199-1204.
6. SCHARTON-KERSTEN, T., et al. 1995. IL-12 is required for NK cell activation and subsequent Th1 cell development in experimental leishmaniasis. J. Immunol. 154: 5320-5330.
7. SZABO, S. J., et al. 1995. Developmental commitment to the Th2 lineage by extinction of IL-12 signaling. Immunity 2: 665-675.
8. COUTELIER, J. P., et al. 1995. Interleukin-12 gene expression after viral infection in the mouse. J. Virol. 69: 1955-1958.
9. ORANGE, J. S., et al. 1995. An absolute and restricted requirement for IL-12 in natural killer cell IFN-γ production and anti-viral defense. Studies of natural killer and T-cell responses in contrasting viral infections. J. Immunol. 156: 1138-1142.
10. ORANGE, J. S., et al. 1995. Requirement for natural killer (NK) cell-produced interferon-γ in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J. Exp. Med. 182: 1045-1056.
11. LUKACHER, A. E., et al. 1984. In vivo effector function of influenza virus specific cytotoxic T lymphocytes is highly specific. J. Exp. Med. 160: 814-826.
12. LUKACHER, A. E., et al. 1986. T lymphocyte function in recovery from experimental viral infection: The influenza model. In Mechanisms of Host Resistance to Infectious Agents, Tumors and Allografts. R. M. Steinman & R. J. North, Eds.: 233. Rockefeller Press. New York.
13. TAYLOR, P. M., et al. 1986. Influenza nucleoprotein specific cytotoxic T cell clones are protective in vivo. Immunology 58: 417-420.
14. ADA, G. L., et al. 1986. The immune response to influenza infection. Curr. Top. Microbiol. Immunol. 128: 1-54.
15. ORANGE, J. S., et al. 1994. Effects of IL-12 on the response and susceptibility to experimental viral infections. J. Immunol. 152: 1253-1264.
16. ORANGE, J. S., et al. 1995. Mechanism of interleukin-12-mediated toxicities during experimental viral infections: Role of tumor necrosis factor and glucocorticoids. J. Exp. Med. 181: 901-914.
17. SCHUNS, E. C. J., et al. 1995. Interleukin-12 stimulates an antiviral type 1 cytokine response but lacks adjuvant activity in interferon-γ-receptor-deficient mice. J. Immunol. 155: 2525-2532.